1. science
2. medicine
3. oncology

12TH INTERNATIONAL ULTMANN
CHICAGO LYMPHOMA SYMPOSIUM
April 24-25, 2015
SYMPOSIUM CO-CHAIRS
Sonali M. Smith, MD
The University of Chicago
Andrew M. Evens, DO, MSc
Tufts Medical Center
Jane N. Winter, MD
Northwestern University
W CHICAGO CITY CENTER
172 West Adams Street
Chicago, IL 60603
Join us for the 12th International Ultmann Chicago Lymphoma
Symposium (IUCLS), an annual conference dedicated solely
to the science and clinical care of lymphoma hosted by the
esteemed University of Chicago.
The goal of this educational activity is to facilitate a forum for
physicians, researchers, and other allied healthcare professionals
to discuss biologic, diagnostic, and therapeutic aspects of
non-Hodgkin lymphoma.
Register online at: http://www.chicagolymphoma.com
SYMPOSIUM DESCRIPTION
The International Ultmann Chicago Lymphoma Symposium (IUCLS) is an annual conference dedicated
solely to the science and clinical care of lymphoma. It has been organized to honor the achievements of
Dr. John Ultmann, a pioneer in the treatment of lymphoma, who devoted his life to the understanding of
this disease. He was particularly known for his work on the staging of Hodgkin lymphoma and the utility
of staging as a guide for treatment.
We are fortunate to have a multitude of the world’s experts in lymphoma speak each year at the conference.
The audience is comprised of regional practicing oncologists, advanced nurse practitioners and physician
assistants, residents, fellows, and the Chicago academic community that includes five academic centers.
This year’s program in April 2015 represents the 12th IUCLS.
This is a certified continuing medical education (CME) activity that focuses on the biologic, diagnostic, and
therapeutic aspects of Hodgkin lymphoma and non-Hodgkin lymphoma. The format of the meeting includes
a combination of expert presentations, interactive case discussions, poster/abstract presentations, and
an opportunity for question-and-answer debates. The IUCLS is a two-day meeting held Friday afternoon
and Saturday morning and early afternoon at the W Chicago City Center. Friday afternoon concentrates
on the scientific and translational aspects of lymphoma, while Saturday has a clinical focus.
LEARNING OBJECTIVES
At the conclusion of this educational activity, participants will be able to:
• Understand immunotherapy and CAR-T cells in lymphoma
• Describe the importance of PD-1 signaling in lymphoma
• Identify new molecular and genetic targets in DLBCL
• Treat frontline follicular lymphoma with biologic agents versus chemotherapy
• Understand the state of the art treatment for HL and describe the late toxicities associated
with treatment
• Discuss the role of stem cell transplant in relapsed T-cell lymphoma
Please join us for what promises to be an informative and thought-provoking conference!
CALL FOR ABSTRACTS
Abstract submissions are now being accepted! The abstract submission deadline is Monday, March
23, 2015. Additional information at chicagolymphoma.com/call-for-abstracts/.
TARGET AUDIENCE
The symposium has been designed for medical hematologists/oncologists, radiation oncologists,
pathologists, surgical oncologists, fellows-in-training, oncology nurses, and allied health professionals
committed to the prevention, management, and elimination of lymphoma.
ACCREDITATION AND CREDIT DESIGNATION
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing medical education for physicians.
GENERAL SESSIONS (FRIDAY and SATURDAY)
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum 9.25
AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent
of their participation in the activity.
Nurses and other healthcare professionals will receive a Certificate of Participation. For information
on the applicability and acceptance of certificates of participation for educational activities certified
for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your
professional licensing board.
EDUCATIONAL GRANTS/COMMERCIAL SUPPORT
A complete listing of commercial support received will be provided in the conference materials.
LOCATION AND ACCOMMODATIONS
The conference will take place at W Chicago City Center
172 West Adams Street
Chicago, IL 60603
312-332-1200 / wchicagocitycenter.com
Set in the middle of the famed Chicago Loop, W
Chicago City Center is close to the Willis Tower
(formerly the Sears Tower), the Art Institute of
Chicago, music at Millennium Park, and the theater
district. The W is a world-class venue, and Chicago
is a world-class city. After the conference adjourns
each day you can enjoy premium shopping, beautiful
architecture, famous art, and award-winning theater
just a short walk away. Step out – the Windy City
surrounds you.
We are pleased to offer a special discounted rate
of $189.00 per night for single and $209.00 per
night for double occupancy during the conference.
Room reservations must be made by April 1, 2015
to guarantee the reduced rate. After the cut-off
date, it is at the hotel’s discretion whether to accept
additional reservations, which will be subject to
prevailing group rates based on availability. All
rates are subject to state and city taxes and must
be guaranteed and accompanied by a first night
room deposit or guaranteed with a major credit
card. Check-in time is 3 pm and check-out time is
12 pm. Individual reservations can be cancelled 24
hours or more prior to arrival without penalty. If a
reservation is cancelled within 24 hours of arrival,
a one (1) night room and tax charge will apply.
To reserve a room at this special rate, please call the hotel toll free at 312-917-5782 and identify yourself
as part of the University of Chicago International Ultmann Chicago Lymphoma Symposium 2015 or
book online at https://www.starwoodmeeting.com/StarGroupsWeb/res?id=1410219401&key=1B35EB1A.
Parking: The daily parking fee at the W Chicago City Center is $25 for local registered attendees driving
to the conference.
Chicago is truly a city with something for everyone! To help plan your stay in Chicago visit:
www.choosechicago.com.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event
this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible
for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
SYMPOSIUM CO-CHAIRS
Sonali M. Smith, MD
Associate Professor of Medicine
Section of Hematology/Oncology
Director, Lymphoma Program
The University of Chicago
Chicago, IL
Andrew M. Evens, DO, MSc
Professor of Medicine
Chief, Division of Hematology/Oncology
Tufts University School of Medicine
Director, Tufts Cancer Center
Tufts Medical Center
Boston, MA
Jane N. Winter, MD
Professor of Medicine
Division of Hematology/Oncology
Northwestern University Feinberg
School of Medicine
Chicago, IL
Mary Gospodarowicz, MD, FRCPC,
FRCR (Hon)
Chief, Radiation Medicine Program
Princess Margaret Hospital/University
Health Network
Professor, Department of Radiation
Oncology
University of Toronto
Ontario, Canada
Adam Petrich, MD
Assistant Professor of Medicine and
Hematology and Oncology
Northwestern University Feinberg
School of Medicine
Chicago, IL
INVITED SPEAKERS
Jeremy S. Abramson, MD, MMSc
Director, Lymphoma Program
Massachusetts General Hospital
Cancer Center
Assistant Professor of Medicine
Harvard Medical School
Boston, MA
Nancy L. Bartlett, MD
Professor of Medicine
Koman Chair in Medical Oncology
Washington University School
of Medicine
St. Louis, MO
Catherine M. Bollard, MD
Professor of Pediatrics and
Microbiology, Immunology, Tropical
Medicine
Director, Program for Cell Enhancement
and Technologies for Immunotherapy
Children’s National Health System
The George Washington University
Washington, DC
Timothy S. Fenske, MD
Associate Professor of Medicine
Division of Hematology & Oncology
Medical College of Wisconsin
Milwaukee, WI
Nathan Fowler, MD
Associate Professor of Medicine
Co-Director, Clinical and Translational
Research
Lead, New Drug Development
Department of Lymphoma/Myeloma
MD Anderson Cancer Center
Houston, TX
Richard R. Furman, MD
Morton Coleman, MD Distinguished
Associate Professor of Medicine
Director, CLL Research Center
Weill Cornell Medical College
New York, NY
Michael Hallek, MD
Director
Department I of Internal Medicine
Center of Integrated Oncology
Köln-Boon
University of Cologne
Cologne, Germany
Reem Karmali, MD
Assistant Professor of Medicine
Division of Hematology, Oncology,
and Cell Therapy
Rush University Medical Center/
Rush University
Chicago, IL
Justin Kline, MD
Assistant Professor of Medicine
The University of Chicago
Chicago, IL
Chadi Nabhan, MD, FACP
Associate Professor of Medicine
Medical Director, Clinical Cancer
Center and Cancer Clinics
The University of Chicago
Chicago, IL
Owen O’Connor, MD, PhD
Professor of Medicine and Experimental
Therapeutics
Director of the Center for Lymphoid
Malignancies
Co-Program Director of the Lymphoid
Development and Malignancy Program
Herbert Irving Comprehensive
Cancer Center
Columbia University Medical Center
New York, NY
Margaret A. Shipp, MD
Chief, Division of Hematologic Neoplasia
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, MA
Mitchell Smith, MD, PhD
Director, Lymphoid Malignancy Program
Department of Hematology and
Medical Oncology
Taussig Cancer Institute
Cleveland Clinic
Cleveland, OH
Eduardo Sotomayor, MD
Susan and John Sykes Endowed Chair
in Hematologic Malignancies
Scientific Director, DeBartolo Family
Personalized Medicine Institute
Professor of Oncological Sciences,
Pathology, and Cell Biology
University of South Florida College
of Medicine
Tampa, FL
Patrick Stiff, MD
Coleman Professor of Oncology
Director, Cancer Center
FCO Division Director, Hematology/
Oncology
Medical Director, Cancer Center
Chicago, IL
ADVISORY COMMITTEE
Timothy S. Fenske, MD
Associate Professor of Medicine
Division of Hematology & Oncology
Medical College of Wisconsin
Milwaukee, WI
Stephanie A. Gregory, MD
The Elodia Kehm Chair of
Hematology
Professor of Medicine
Director, Section of Hematology
Rush University Medical Center/
Rush University
Chicago, IL
Chadi Nabhan, MD, FACP
Associate Professor of Medicine
Medical Director, Clinical Cancer
Center and Cancer Clinics
The University of Chicago
Chicago, IL
Adam Petrich, MD
Assistant Professor of Medicine and
Hematology and Oncology
Northwestern University Feinberg
School of Medicine
Chicago, IL
David J. Peace, MD
Professor of Medicine
Director, Hematology and Medical
Oncology Training Program
University of Illinois at Chicago
Chicago, IL
Scott E. Smith MD, PhD, FACP
Professor of Medicine
Cardinal Bernardin Cancer Center
Loyola University Chicago
Medical Center
Maywood, IL
FACULTY DISCLOSURE
It is the policy of the University of Chicago to ensure balance, independence, objectivity, and scientific rigor in all its
individually sponsored or jointly sponsored educational activities. Individuals who are in a position to control the content of
this educational activity are required to disclose all relevant financial relationships with any commercial interest related to
the subject matter of the educational activity. Mechanisms to ensure that presentations are free from commercial bias are
in place. Faculty will also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in
their presentation. Full disclosure of this information will be published in the activity materials.
SYMPOSIUM AGENDA
FRIDAY, APRIL 24, 2015
12:00 pm REGISTRATION
1:00-1:10
Welcome and Introduction
1:10-1:40
Late Effects of HL Treatment: Are We Doing Any Better?
Mary Gospodarowicz, MD, FRCPC, FRCR (Hon)
1:40-2:10 Beyond BCR Signaling: New Targets and Therapeutic Approaches in
Lymphoma, Owen O’Connor, MD, PhD
2:10-2:40 The Clinical Impact of Mantle Cell Lymphoma Biology
Eduardo Sotomayor, MD
2:40-3:00 REFRESHMENT BREAK
3:00-3:30 Next Steps in the Development and Application of CAR T-Cell Therapy
Catherine M. Bollard, MD
3:30-4:00 Immunology for the Lymphoma Clinician: How T-Cells and B-Cells Interact
Justin Kline, MD
SCIENTIFIC KEYNOTE
4:00-5:00
The Translational Path of PD-1 Therapy in Lymphoma
Margaret A. Shipp, MD
5:00-6:15 pm ABSTRACT/POSTER HIGHLIGHTS AND WELCOME RECEPTION
EXHIBITS OPEN 1:00–5:00 pm
7:00 am REGISTRATION AND CONTINENTAL BREAKFAST
8:00-8:10 Welcome and Introduction
DEBATES IN LYMPHOMA
8:10-9:10 Debates in Lymphoma: Chemotherapy Should Be Part of Initial Treatment
for High Tumor Burden Follicular Lymphoma
Mitchell Smith, MD, PhD (PRO) vs. Nathan Fowler, MD (CON)
9:10-10:10 Debates in Lymphoma: Autologous SCT Should Be a Treatment Option for
Relapsed Mantle Cell Lymphoma
Timothy S. Fenske, MD (PRO) vs. Patrick Stiff, MD (CON)
10:10-10:40
Response Adapted Therapy in Hodgkin Lymphoma: How Should It Be
Integrated for the Treatment of Patients, Nancy L. Bartlett, MD
10:40-11:00 REFRESHMENT BREAK
11:00-11:30 Molecular Prognostication of CLL in the Era of Novel Therapeutics
Richard R. Furman, MD
SCIENTIFIC KEYNOTE
11:30-12:30
Optimal Therapeutic Strategies for Patients with CLL in the Current Era
Michael Hallek, MD
12:30-1:30 pm LUNCH
1:30-2:00
Case Discussions, Chadi Nabhan, MD, FACP, Adam Petrich, MD, and Reem Karmali, MD
2:00-2:30
Prognostication of DLBCL in the Modern Era, Jane N. Winter, MD
2:30-3:00
Treatment of High Risk DLBCL, Jeremy S. Abramson, MD, MMSc
3:00 pm
ADJOURN
EXHIBITS OPEN 7:00 am –2:00 pm
Program agenda and speaker selection subject to change.
CLIP HERE TO MAIL IN REGISTRATION FORM
SATURDAY, APRIL 25, 2015
✁
REGISTRATION
HOW TO REGISTER
ONLINE http://cme.uchicago.edu (credit card payment only)
To pay by check, you must mail your registration with payment to:
MAIL
The University of Chicago
Center for Continuing Medical Education
c/o Chicago Lymphoma 2015
950 East 61st Street, Suite 101
Chicago, IL 60637
The registration fee includes symposium materials, an electronic syllabus, continental breakfast, refreshment breaks,
lunch, welcome reception, and poster viewing. You may register online or via U.S. mail. While registration is open
until the start of the meeting, we encourage early registration to enable us to provide the best possible service
to participants.
On or Before
March 20
Between
March 21April 23
Onsite
Registration
April 24-25
Physician
$225
$275
$325
Industry
$400
$500
$550
Nurse/Other Health Professionals
$125
$150
$175
Resident/Fellow (fax letter of verification to 773-702-1736)
$75
$100
$125
Total $_________
PAYMENT
o Check enclosed (U.S. funds only), payable to University of Chicago (Tax ID# 36-2177139)
CONTACT INFORMATION
Name
Degree
Specialty
Organization
Mailing Address
City
Phone
State
Zip
Fax
Email
PLEASE CHECK ALL THAT APPLY
o You must check this box if you do not want your mailing address shared with conference participants and
exhibitors (if applicable).
Do you plan to attend the Friday Poster Viewing and Welcome Reception? o Yes o No
Please tell us how you found out about this activity, check all that apply:
o Colleague o Save the Date o Brochure o Internet o Email o Journal Ad o Previous Attendance o Other
CANCELLATION POLICY
If you cancel your participation in this conference, your registration fee, less a $100 administrative fee, will be
refunded when written notification is received by March 27, 2015. No refunds will be issued after March 27, 2015.
ACCESSIBILITY
The University of Chicago is committed to providing equal access appropriate to need and circumstance and complies fully with the
legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at
773-702-1056 or via email at [email protected].
For additional information about this activity, please call the Center for Continuing Medical Education at 773-702-1056.
W Chicago City Center
172 West Adams Street
Chicago, IL 60603
April 24-25, 2015
12TH INTERNATIONAL
ULTMANN CHICAGO
LYMPHOMA SYMPOSIUM
The University of Chicago
Center for Continuing Medical Education
950 East 61st Street, Chicago, IL 60637
PLEASE POST
DLC
PAID
NON-PROFIT
ORGANIZATION
U.S. POSTAGE